BACKGROUND: African Americans (AA) disproportionately develop lupus nephritis (LN) relative to European Americans and familial clustering supports causative genes. Since MYH9 underlies approximately 40% of end-stage renal disease (ESRD) in AA, we tested for genetic association with LN. METHODS: Seven MYH9 single nucleotide polymorphisms (SNPs) and the E1 risk haplotype were tested for association with LN in three cohorts of AA. RESULTS: A preliminary analysis revealed that the MYH9 E1 risk haplotype was associated with ESRD in 25 cases with presumed systemic lupus erythematosus (SLE)-associated ESRD, compared to 735 non-SLE controls (odds ratio 3.1; p = 0.010 recessive). Replication analyses were performed in 583 AA with SLE in the PROFILE cohort (318 with LN; 265 with SLE but without nephropathy) and 60 AA from the NIH (39 with LN; 21 with SLE but without nephropathy). Analysis of the NIH and larger PROFILE cohorts, as well as a combined analysis, did not support this association. CONCLUSIONS: These results suggest that AA with ESRD and coincident SLE who were recruited from dialysis clinics more likely have kidney diseases in the MYH9-associated spectrum of focal segmental glomerulosclerosis. PROFILE and NIH participants, recruited from rheumatology practices, demonstrate that MYH9 does not contribute substantially to the development of LN in AA. Copyright 2010 S. Karger AG, Basel.
BACKGROUND: African Americans (AA) disproportionately develop lupus nephritis (LN) relative to European Americans and familial clustering supports causative genes. Since MYH9 underlies approximately 40% of end-stage renal disease (ESRD) in AA, we tested for genetic association with LN. METHODS: Seven MYH9 single nucleotide polymorphisms (SNPs) and the E1 risk haplotype were tested for association with LN in three cohorts of AA. RESULTS: A preliminary analysis revealed that the MYH9 E1 risk haplotype was associated with ESRD in 25 cases with presumed systemic lupus erythematosus (SLE)-associated ESRD, compared to 735 non-SLE controls (odds ratio 3.1; p = 0.010 recessive). Replication analyses were performed in 583 AA with SLE in the PROFILE cohort (318 with LN; 265 with SLE but without nephropathy) and 60 AA from the NIH (39 with LN; 21 with SLE but without nephropathy). Analysis of the NIH and larger PROFILE cohorts, as well as a combined analysis, did not support this association. CONCLUSIONS: These results suggest that AA with ESRD and coincident SLE who were recruited from dialysis clinics more likely have kidney diseases in the MYH9-associated spectrum of focal segmental glomerulosclerosis. PROFILE and NIH participants, recruited from rheumatology practices, demonstrate that MYH9 does not contribute substantially to the development of LN in AA. Copyright 2010 S. Karger AG, Basel.
Authors: Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler Journal: Nat Genet Date: 2008-09-14 Impact factor: 38.330
Authors: Amber M Reeves-Daniel; Samy S Iskandar; Donald W Bowden; Meredith A Bostrom; Pamela J Hicks; Mary E Comeau; Carl D Langefeld; Barry I Freedman Journal: Am J Kidney Dis Date: 2010-01-29 Impact factor: 8.860
Authors: Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden Journal: Kidney Int Date: 2009-01-28 Impact factor: 10.612
Authors: John B Harley; Marta E Alarcón-Riquelme; Lindsey A Criswell; Chaim O Jacob; Robert P Kimberly; Kathy L Moser; Betty P Tsao; Timothy J Vyse; Carl D Langefeld; Swapan K Nath; Joel M Guthridge; Beth L Cobb; Daniel B Mirel; Miranda C Marion; Adrienne H Williams; Jasmin Divers; Wei Wang; Summer G Frank; Bahram Namjou; Stacey B Gabriel; Annette T Lee; Peter K Gregersen; Timothy W Behrens; Kimberly E Taylor; Michelle Fernando; Raphael Zidovetzki; Patrick M Gaffney; Jeffrey C Edberg; John D Rioux; Joshua O Ojwang; Judith A James; Joan T Merrill; Gary S Gilkeson; Michael F Seldin; Hong Yin; Emily C Baechler; Quan-Zhen Li; Edward K Wakeland; Gail R Bruner; Kenneth M Kaufman; Jennifer A Kelly Journal: Nat Genet Date: 2008-01-20 Impact factor: 38.330
Authors: W H Linda Kao; Michael J Klag; Lucy A Meoni; David Reich; Yvette Berthier-Schaad; Man Li; Josef Coresh; Nick Patterson; Arti Tandon; Neil R Powe; Nancy E Fink; John H Sadler; Matthew R Weir; Hanna E Abboud; Sharon G Adler; Jasmin Divers; Sudha K Iyengar; Barry I Freedman; Paul L Kimmel; William C Knowler; Orly F Kohn; Kristopher Kramp; David J Leehey; Susanne B Nicholas; Madeleine V Pahl; Jeffrey R Schelling; John R Sedor; Denyse Thornley-Brown; Cheryl A Winkler; Michael W Smith; Rulan S Parekh Journal: Nat Genet Date: 2008-09-14 Impact factor: 38.330
Authors: Keith L Keene; Josyf C Mychaleckyj; Shelly G Smith; Tennille S Leak; Peter S Perlegas; Carl D Langefeld; Barry I Freedman; Stephen S Rich; Donald W Bowden; Michèle M Sale Journal: Diabetes Date: 2008-01-09 Impact factor: 9.461
Authors: Kui Liu; Quan-Zhen Li; Angelica M Delgado-Vega; Anna-Karin Abelson; Elena Sánchez; Jennifer A Kelly; Li Li; Yang Liu; Jinchun Zhou; Mei Yan; Qiu Ye; Shenxi Liu; Chun Xie; Xin J Zhou; Sharon A Chung; Bernardo Pons-Estel; Torsten Witte; Enrique de Ramón; Sang-Cheol Bae; Nadia Barizzone; Gian Domenico Sebastiani; Joan T Merrill; Peter K Gregersen; Gary G Gilkeson; Robert P Kimberly; Timothy J Vyse; Il Kim; Sandra D'Alfonso; Javier Martin; John B Harley; Lindsey A Criswell; Edward K Wakeland; Marta E Alarcón-Riquelme; Chandra Mohan Journal: J Clin Invest Date: 2009-04 Impact factor: 14.808
Authors: Barry I Freedman; Carl D Langefeld; Kelly K Andringa; Jennifer A Croker; Adrienne H Williams; Neva E Garner; Daniel J Birmingham; Lee A Hebert; Pamela J Hicks; Mark S Segal; Jeffrey C Edberg; Elizabeth E Brown; Graciela S Alarcón; Karen H Costenbader; Mary E Comeau; Lindsey A Criswell; John B Harley; Judith A James; Diane L Kamen; S Sam Lim; Joan T Merrill; Kathy L Sivils; Timothy B Niewold; Neha M Patel; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Jane E Salmon; Betty P Tsao; Keisha L Gibson; Joyce R Byers; Anna K Vinnikova; Janice P Lea; Bruce A Julian; Robert P Kimberly Journal: Arthritis Rheumatol Date: 2014-02 Impact factor: 10.995
Authors: Ilana B Richman; Kimberly E Taylor; Sharon A Chung; Laura Trupin; Michelle Petri; Edward Yelin; Robert R Graham; Annette Lee; Timothy W Behrens; Peter K Gregersen; Michael F Seldin; Lindsey A Criswell Journal: Arthritis Rheum Date: 2012-10
Authors: C P Lin; I Adrianto; C J Lessard; J A Kelly; K M Kaufman; J M Guthridge; B I Freedman; J-M Anaya; M E Alarcón-Riquelme; B A Pons-Estel; J Martin; S Glenn; A Adler; S-C Bae; S-Y Park; S-Y Bang; Y-W Song; S A Boackle; E E Brown; J C Edberg; G S Alarcón; M A Petri; L A Criswell; R Ramsey-Goldman; J D Reveille; L M Vila; G S Gilkeson; D L Kamen; J Ziegler; C O Jacob; A Rasmussen; J A James; R P Kimberly; J T Merrill; T B Niewold; R H Scofield; A M Stevens; B P Tsao; T J Vyse; C D Langefeld; K L Moser; J B Harley; P M Gaffney; C G Montgomery Journal: Genes Immun Date: 2011-12-22 Impact factor: 2.676
Authors: Liran I Shlush; Sivan Bercovici; Walter G Wasser; Guennady Yudkovsky; Alan Templeton; Dan Geiger; Karl Skorecki Journal: BMC Med Genomics Date: 2010-10-18 Impact factor: 3.063